Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bivalirudin vs Heparin for PCI in Angina and NSTEMI
NCT02448550Phase 3Terminated
- Sponsor
- Kaiser Permanente
- Start
- May 2015
- Primary completion
- May 2016
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bivalirudin in stable angina, unstable angina, non-ST segment elevation myocardial infarction (NSTEMI), sponsored by Kaiser Permanente. Started May 2015; status: terminated.
02
Drugs
bivalirudin
03
Conditions
stable anginaunstable anginanon-ST segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT02448550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02448550.